MOVIPREP

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, United Kingdom, South Africa

Active ingredients

The drug MOVIPREP contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII G2M7P15E5P - POLYETHYLENE GLYCOL 3350
 

High molecular weight (4000) macrogols are long linear polymers which retain water molecules by means of hydrogen bonds. When administered by the oral route, they lead to an increase in volume of intestinal fluids.

 
Read more about Macrogol
2
UNII 36KCS0R750 - SODIUM SULFATE ANHYDROUS
 

Sodium Sulfate Anhydrous is the anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions.

 
Read more about Sodium sulfate
3
UNII 451W47IQ8X - SODIUM CHLORIDE
 

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

 
Read more about Sodium chloride
4
UNII 660YQ98I10 - POTASSIUM CHLORIDE
 

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

 
Read more about Potassium chloride
5
UNII PQ6CK8PD0R - ASCORBIC ACID
 

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.

 
Read more about Vitamin C
6
UNII S033EH8359 - SODIUM ASCORBATE
 

Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs.

 
Read more about Vitamin C

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MOVIPREP Oral solution MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A06AD65 Macrogol, combinations A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives
Discover more medicines within A06AD65

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02359499
EE Ravimiamet 1479416, 1479427, 1479438, 1479449, 1479450, 1479461
ES Centro de información online de medicamentos de la AEMPS 340093781647, 68125, 73642
FI Lääkealan turvallisuus- ja kehittämiskeskus 075187
FR Base de données publique des médicaments 61095956
GB Medicines & Healthcare Products Regulatory Agency 113805, 113808, 113811, 182439, 182442
HR Agencija za lijekove i medicinske proizvode HR-H-033715132
IL מִשְׂרַד הַבְּרִיאוּת 6679
JP 医薬品医療機器総合機構 7990102A1024
LT Valstybinė vaistų kontrolės tarnyba 1054742, 1054743, 1058559, 1058560, 1058561, 1058562, 1058563
MT Medicines Authority MA930/00101
NL Z-Index G-Standaard, PRK 83291
NZ Medicines and Medical Devices Safety Authority 12733, 18009
PL Rejestru Produktów Leczniczych 100248228, 100404272, 100449211, 100456020
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W66152001, W66152002, W66152003, W66152004, W66152005, W66152006
ZA Health Products Regulatory Authority 42/11.5/0407

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.